Seven misconceptions regarding the Gaia hypothesisMOODY, David E.Climatic change. 2012, Vol 113, Num 2, pp 277-284, issn 0165-0009, 8 p.Article

Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomesYAN CHANG; MOODY, David E.European journal of clinical pharmacology. 2005, Vol 60, Num 12, pp 875-881, issn 0031-6970, 7 p.Article

Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patchesMOODY, David E; CHEEVER, Matthew L.Journal of analytical toxicology. 2001, Vol 25, Num 3, pp 190-197, issn 0146-4760Article

Urinary excretion of 4-hydroxyamphetamine and amphetamine in male and female Sprague-Dawley and Dark Agouti rats following multiple doses of amphetamineLAW, Michael Y. L; MOODY, David E.Toxicology letters. 2000, Vol 117, Num 3, pp 139-144, issn 0378-4274Article

Variables in human liver microsome preparation : Impact on the kinetics of L-α-acetylmethadol (LAAM) N-demethylation and dextromethorphan O-demethylationNELSON, Ann C; WEI HUANG; MOODY, David E et al.Drug metabolism and disposition. 2001, Vol 29, Num 3, pp 319-325, issn 0090-9556Article

The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray lonization-tandem mass spectrometryWEI HUANG; MOODY, David E; MCCANCE-KATZ, Elinore F et al.Therapeutic drug monitoring. 2006, Vol 28, Num 2, pp 245-251, issn 0163-4356, 7 p.Article

Novel metabolites of buprenorphine detected in human liver microsomes and human urineYAN CHANG; MOODY, David E; MCCANCE-KATZ, Elinore F et al.Drug metabolism and disposition. 2006, Vol 34, Num 3, pp 440-448, issn 0090-9556, 9 p.Article

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersMIDDLETON, Lisa S; NUZZO, Paul A; LOFWALL, Michelle R et al.Addiction (Abingdon. Print). 2011, Vol 106, Num 8, pp 1460-1473, issn 0965-2140, 14 p.Article

Cocaine and its major metabolites in plasma and urine samples from patients in an urban emergency medicine settingWILLIAMS, Robert H; MAGGIORE, Jack A; SHAH, Steve M et al.Journal of analytical toxicology. 2000, Vol 24, Num 7, pp 478-481, issn 0146-4760Article

The effects of collection methods on oral fluid codeine concentrationsO'NEAL, Carol L; CROUCH, Dennis J; ROLLINS, Douglas E et al.Journal of analytical toxicology. 2000, Vol 24, Num 7, pp 536-542, issn 0146-4760Article

Consumption and quantitation of Δ⁹-tetrahydrocannabinol in commercially available hemp seed oil productsBOSY, T. Z; COLET, K. A.Journal of analytical toxicology. 2000, Vol 24, Num 7, pp 562-566, issn 0146-4760Article

Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytesKLETTET, Kevin L; ANDERSON, Cynthia J; POCH, Gregory K et al.Journal of analytical toxicology. 2000, Vol 24, Num 7, pp 550-556, issn 0146-4760Article

Effect of Rifampin and Nelfinavir on the Metabolism of Methadone and Buprenorphine in Primary Cultures of Human HepatocytesMOODY, David E; FANG, Wenfang B; LIN, Shen-Nan et al.Drug metabolism and disposition. 2009, Vol 37, Num 12, pp 2323-2329, issn 0090-9556, 7 p.Article

Buprenorphine duration of action : Mu-opioid receptor availability and pharmacokinetic and behavioral indicesGREENWALD, Mark; JOHANSON, Chris-Ellyn; BUELLER, Joshua et al.Biological psychiatry (1969). 2007, Vol 61, Num 1, pp 101-110, issn 0006-3223, 10 p.Article

Buprenorphine tablet versus liquid : A clinical trial comparing plasma levels, efficacy, and symptomsCHAWARSKI, Marek C; MOODY, David E; PAKES, Juliana et al.Journal of substance abuse treatment. 2005, Vol 29, Num 4, pp 307-312, issn 0740-5472, 6 p.Article

Relative bioavailability of different buprenorphine formulations under chronic dosing conditionsSTRAIN, Eric C; MOODY, David E; STOLLER, Kenneth B et al.Drug and alcohol dependence. 2004, Vol 74, Num 1, pp 37-43, issn 0376-8716, 7 p.Article

Simultaneous determination of Δ⁹-tetrahydrocannabinol and 11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometryWEI HUANG; MOODY, David E; ANDRENYAK, David M et al.Journal of analytical toxicology. 2001, Vol 25, Num 7, pp 531-537, issn 0146-4760Article

Special Issue: Society of Forensic Toxicologists, IncANDRENYAK, David M; CROUCH, Dennis J; FOLTZ, Rodger L et al.Journal of analytical toxicology. 2000, Vol 24, Num 7, issn 0146-4760, 213 p.Serial Issue

The characterization of human urine for specimen validity determination in workplace drug testing: a reviewCOOK, Janine Denis; CAPLAN, Yale H; LODICO, Charles P et al.Journal of analytical toxicology. 2000, Vol 24, Num 7, pp 579-588, issn 0146-4760Article

Detection times and analytical performance of commercial urine opiate immunoassays following heroin administrationSMITH, Michael L; SHIMOMURA, Eric T; SUMMERS, Jacquelyn et al.Journal of analytical toxicology. 2000, Vol 24, Num 7, pp 522-529, issn 0146-4760Article

Patterns of Free (Unconjugated) Buprenorphine, Norbuprenorphine, and Their Glucuronides in Urine Using Liquid Chromatography―Tandem Mass SpectrometryMCMILLIN, Gwendolyn A; DAVIS, Rebecka; CARLISLE, Heidi et al.Journal of analytical toxicology. 2012, Vol 36, Num 2, pp 81-87, issn 0146-4760, 7 p.Article

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxoneBRUCE, R. Douglas; ALTICE, Frederick L; FRIEDLAND, Gerald H et al.Drug and alcohol dependence. 2009, Vol 105, Num 3, pp 234-239, issn 0376-8716, 6 p.Article

Interaction between buprenorphine and atazanavir or atazanavir/ritonavirMCCANCE-KATZ, Elinore F; MOODY, David E; MORSE, Gene D et al.Drug and alcohol dependence. 2007, Vol 91, Num 2-3, pp 269-278, issn 0376-8716, 10 p.Article

An injection depot formulation of buprenorphine : extended biodelivery and effectsSIGMON, Stacey C; MOODY, David E; NUWAYSER, Elie S et al.Addiction (Abingdon. Print). 2006, Vol 101, Num 3, pp 420-432, issn 0965-2140, 13 p.Article

Determination of riboflavin by high-performance liquid chromatography with riboflavin-depleted urine as calibration and control matrixMENG CHEN; ANDRENYAK, David M; MOODY, David E et al.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 147-150, issn 1570-0232, 4 p.Article